| P2093 | author name string | Demetri GD | |
| | Fletcher CD | |
| | Cohen PS | |
| | Fletcher JA | |
| | Zhu MJ | |
| | Ou WB | |
| P2860 | cites work | Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis | Q24292477 |
| | Formation of signal transfer complexes between stem cell and platelet-derived growth factor receptors and SH2 domain proteins in vitro | Q24306912 |
| | Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. | Q27824798 |
| | Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors | Q28118852 |
| | Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways | Q28274882 |
| | The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136 | Q28275577 |
| | Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells | Q28286939 |
| | Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors | Q29618610 |
| | Cell proliferation through forced engagement of c-Kit and Flt-3. | Q33947825 |
| | PDGFRA activating mutations in gastrointestinal stromal tumors. | Q34169772 |
| | Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. | Q34524914 |
| | Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial | Q34551403 |
| | Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells | Q40580990 |
| | STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications | Q40783216 |
| | Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells | Q43615388 |
| | Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). | Q44790860 |
| | KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications | Q44956779 |
| | Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs). | Q45003972 |
| | Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants | Q45247236 |
| P433 | issue | 44 | |
| P304 | page(s) | 6386-6395 | |
| P577 | publication date | 2007-04-23 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance | |
| P478 | volume | 26 | |